Drugs giant Eli Lilly caps monthly insulin costs in US at $35
The cap on the diabetes medication by the drugs giant could bring cost relief to many Americans.
Stay updated with breaking news from Insulin Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The cap on the diabetes medication by the drugs giant could bring cost relief to many Americans.
Adults with diabetes with commercial health insurance who use insulin manufactured by Eli Lilly and Company will have out-of-pocket costs capped at $35 per month, according to a company press release. Effective immediately, Lilly announced it will cap the out-of-pocket cost of insulin at $35 per month for U.S. residents with commercial insurance, as well those without health insurance, through
The cap on the diabetes medication by the drugs giant could bring cost relief to many Americans.
Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, as most big pharma insulin is currently produced in-house.